| Selecta Biosciences Partners with Sanofi to Develop Antigen-Specific Immunotherapies for Allergies |
Abstract
|
|
Heather Cartwright |
|
| Biogen Idec Signs Third Antisense Deal of 2012 with Isis Pharmaceuticals |
Abstract
|
|
Heather Cartwright |
|
| Teva Licenses Xenon Pharmaceuticals’ Pain Drug XEN402 as Part of New Strategic Plan |
Abstract
|
|
Heather Cartwright |
|
| Isis Pharmaceuticals Ends 2012 with an Antisense Cancer Alliance with AstraZeneca |
Abstract
|
|
Heather Cartwright |
|
| Wright Medical Bets on BioMimetic Therapeutics with Merger Agreement |
Abstract
|
|
Heather Cartwright |
|
| Reckitt Benckiser Ventures into Vitamins, Minerals and Supplements Market with Schiff Nutrition Purchase |
Abstract
|
|
Heather Cartwright |
|
| BASF Aims for Top Spot in Omega-3 API Market with Pronova BioPharma Acquisition |
Abstract
|
|
Heather Cartwright |
|
| Smith & Nephew Moves into Fast-Growing Bioactive Wound Care Segment with Healthpoint Biotherapeutics Acquisition |
Abstract
|
|
Heather Cartwright |
|
| Amgen Makes Long-Term Investment in Targeted Therapies with deCODE Genetics Purchase |
Abstract
|
|
Heather Cartwright |
|
| Nestlé and Chi-Med Form Joint Venture to Develop Drugs Based on Traditional Chinese Medicine |
Abstract
|
|
Heather Cartwright |
|
